- Home
- PMTS vs CRMD Comparison
PMTS vs CRMD Comparison
Compare PMTS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- CRMD
- Stock Information
- Founded
- PMTS 2007
- CRMD 2006
- Country
- PMTS United States
- CRMD United States
- Employees
- PMTS N/A
- CRMD N/A
- Industry
- PMTS Finance Companies
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- PMTS Finance
- CRMD Health Care
- Exchange
- PMTS Nasdaq
- CRMD Nasdaq
- Market Cap
- PMTS 327.9M
- CRMD 973.3M
- IPO Year
- PMTS 2015
- CRMD 2010
- Fundamental
- Price
- PMTS $25.11
- CRMD $11.40
- Analyst Decision
- PMTS Strong Buy
- CRMD Strong Buy
- Analyst Count
- PMTS 4
- CRMD 7
- Target Price
- PMTS $36.75
- CRMD $17.33
- AVG Volume (30 Days)
- PMTS 51.9K
- CRMD 2.5M
- Earning Date
- PMTS 08-04-2025
- CRMD 08-13-2025
- Dividend Yield
- PMTS N/A
- CRMD N/A
- EPS Growth
- PMTS 1.33
- CRMD N/A
- EPS
- PMTS 1.58
- CRMD 0.28
- Revenue
- PMTS $491,426,000.00
- CRMD $82,553,827.00
- Revenue This Year
- PMTS $14.61
- CRMD $238.38
- Revenue Next Year
- PMTS $12.49
- CRMD $53.52
- P/E Ratio
- PMTS $15.89
- CRMD $41.86
- Revenue Growth
- PMTS 12.81
- CRMD N/A
- 52 Week Low
- PMTS $18.46
- CRMD $3.61
- 52 Week High
- PMTS $35.19
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- PMTS 65.50
- CRMD 39.52
- Support Level
- PMTS $22.88
- CRMD $12.14
- Resistance Level
- PMTS $24.04
- CRMD $17.43
- Average True Range (ATR)
- PMTS 0.62
- CRMD 0.69
- MACD
- PMTS 0.27
- CRMD -0.51
- Stochastic Oscillator
- PMTS 91.45
- CRMD 4.60
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.